Seroba Life Sciences
Investor profile
Venture capital
Deals
10
distinct rounds
Companies
9
backed
Active span
2017–2025
9 yrs
Total round €
€271M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Cambridge Innovation Capital2
- FundPlus2
- Kurma Partners2
- Omnes Capital2
- V-Bio Ventures2
- 3B Future Health Fund1
- BioGeneration Ventures1
- Bpifrance1
- btov Partners1
- Caixa Capital Risc1
- CDP Venture Capital1
- Claris Ventures1
- Edmond de Rothschild Venture Capital1
- eureKARE1
- Evolution Ventures1
- Fast Track Initiative1
- Forbion1
- GIMV1
- Go Capital1
- Hadean Ventures1
- IDInvest Partners1
- Indaco Venture Partners1
- Innogest Capital1
- Invus1
- IP Group PLC1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Complement Therapeutics | Germany | 1 | €72M |
| Coave Therapeutics | France | 2 | €53M |
| Quanta | UK | 1 | €41M |
| Medlumics | Spain | 1 | €34M |
| Storm Therapeutics | UK | 1 | €28M |
| Sibylla Biotech | Italy | 1 | €23M |
| Palliare | Ireland | 1 | €8.0M |
| Shorla Pharma | Ireland | 1 | €7.4M |
| Deciphex | Ireland | 1 | €3.9M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Complement Therapeutics | Series A | €72M | 2023-04 |
| Quanta | Series C | €41M | 2019-06 |
| Medlumics | Series B | €34M | 2017-02 |
| Coave Therapeutics | Series A | €32M | 2025-01 |
| Storm Therapeutics | Series B | €28M | 2022-12 |
| Sibylla Biotech | Series A | €23M | 2022-10 |
| Coave Therapeutics | Series B | €21M | 2021-07 |
| Palliare | Other | €8.0M | 2021-07 |
| Shorla Pharma | Series A | €7.4M | 2020-03 |
| Deciphex | Series B | €3.9M | 2023-01 |